Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

THE TRUTH ABOUT: What are wall street analysts target price for abbott stock - The Untold Story

With a market cap of $190.2 billion, Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and sells a wide range of products across pharmaceuticals, diagnostics, nutrition, and medical devices. It provides innovative healthcare solutions including generic medicines, diagnostic systems, nutritional products, cardiovascular devices, and diabetes care technologies worldwide.

Shares of the Abbott Park, Illinois-based company have underperformed the broader market over the past 52 weeks. ABT stock has decreased 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 12.2%. Moreover, the stock has declined 11.8% on a YTD basis, compared to SPX's 10.3% rise.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.